Inventor
WERTZ CHRISTIAN F
US26 patents
⚠️ This page may combine multiple inventors who share the name “WERTZ CHRISTIAN F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NANOCOPOEIA LLC
12 patentsUS11413290B2Aug 16, 2022
Amorphous solid dispersions of dasatinib and uses thereof
NANOCOPOEIA LLC8 citations93
US11202778B2Dec 21, 2021
Amorphous solid dispersions of dasatinib and uses thereof
NANOCOPOEIA LLC9 citations93
US11324745B2May 10, 2022
Amorphous solid dispersions of dasatinib and uses thereof
NANOCOPOEIA LLC7 citations85
US11298356B1Apr 12, 2022
Amorphous solid dispersions of dasatinib and uses thereof
NANOCOPOEIA LLC7 citations85
US11389450B2Jul 19, 2022
Amorphous nilotinib microparticles and uses thereof
NANOCOPOEIA LLC7 citations83
US11980619B2May 14, 2024
Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and uses
NANOCOPOEIA LLC3 citations74
US11633398B2Apr 25, 2023
Amorphous solid dispersions of dasatinib and uses thereof
NANOCOPOEIA LLC2 citations72
US11559485B2Jan 24, 2023
Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib
NANOCOPOEIA LLC6 citations67
US12053471B2Aug 6, 2024
Amorphous nilotinib microparticles and uses thereof
NANOCOPOEIA LLC0 citations60
US12029740B2Jul 9, 2024
Amorphous nilotinib microparticles and uses thereof
NANOCOPOEIA LLC0 citations60
US12016861B2Jun 25, 2024
Amorphous nilotinib microparticles and uses thereof
NANOCOPOEIA LLC0 citations60
US11998548B2Jun 4, 2024
Amorphous nilotinib microparticles and uses thereof
NANOCOPOEIA LLC0 citations60
HANDA THERAPEUTICS LLC
5 patentsUS12558355B2Feb 24, 2026
Amorphous solid dispersions of dasatinib and uses thereof
HANDA THERAPEUTICS LLC0 citations60
US12544376B2Feb 10, 2026
Amorphous solid dispersions of dasatinib and uses thereof
HANDA THERAPEUTICS LLC0 citations60
US12478625B2Nov 25, 2025
Pharmaceutical compositions and crushable tablets including amorphous solid dispersions of dasatinib and uses
HANDA THERAPEUTICS LLC0 citations60
US12465606B2Nov 11, 2025
Amorphous solid dispersions of dasatinib and uses thereof
HANDA THERAPEUTICS LLC0 citations60
US12433891B2Oct 7, 2025
Amorphous solid dispersions of dasatinib and uses thereof
HANDA THERAPEUTICS LLC0 citations60